{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:09:12Z","timestamp":1757614152142,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"DOI":"10.7759\/cureus.91630","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:08:38Z","timestamp":1757045318000},"source":"Crossref","is-referenced-by-count":0,"title":["A Report on the Use of Biparametric MRI in Prostate Cancer Diagnosis: A Two-Year Single Centre Experience"],"prefix":"10.7759","author":[{"given":"Quadri A","family":"Sanni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiq","family":"Abu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolulope","family":"Ogunfowora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tsejime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Bseikri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amman","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ginepri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahim","family":"Kaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajasekaran","family":"Siddhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel RL","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025, 75:10-45.","journal-title":"CA Cancer J Clin"},{"key":"ref2","unstructured":"BJUI International. NICE guidance - prostate cancer: diagnosis and management. (2019). Accessed: August 20, 2025: http:\/\/journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.14809."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.02.042","article-title":"Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"von Eyben FE","year":"2021","unstructured":"von Eyben FE. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021, 79:e176. 10.1016\/j.eururo.2021.02.042","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet N","year":"2021","unstructured":"Mottet N, van den Bergh RC, Briers E, et al.. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021, 79:243-62. 10.1016\/j.eururo.2020.09.042","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4111\/icu.20240456","article-title":"Evaluating prostate cancer diagnostic methods: the role and relevance of digital rectal examination in modern era","volume":"66","author":"Chung Y","year":"2025","unstructured":"Chung Y, Hong SK. Evaluating prostate cancer diagnostic methods: the role and relevance of digital rectal examination in modern era. Investig Clin Urol. 2025, 66:181-7. 10.4111\/icu.20240456","journal-title":"Investig Clin Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan V","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, et al.. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018, 378:1767-77. 10.1056\/NEJMoa1801993","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb JC","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, et al.. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol. 2016, 69:16-40. 10.1016\/j.eururo.2015.08.052","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey B","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al.. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019, 76:340-51. 10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017170129","article-title":"Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen","volume":"285","author":"Kuhl CK","year":"2017","unstructured":"Kuhl CK, Bruhn R, Kr\u00e4mer N, Nebelung S, Heidenreich A, Schrading S. Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen. Radiology. 2017, 285:493-505. 10.1148\/radiol.2017170129","journal-title":"Radiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani V","year":"2017","unstructured":"Gulani V, Calamante F, Shellock FG, et al.. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017, 16:564-70. 10.1016\/S1474-4422(17)30158-8","journal-title":"Lancet Neurol"},{"key":"ref11","article-title":"Proposal for a council recommendation (CR) on strengthening prevention through early detection: a new approach on cancer screening replacing CR","volume":"88","author":"Directorate-General for Health and Food Safety","year":"2016","unstructured":"Directorate-General for Health and Food Safety. Proposal for a council recommendation (CR) on strengthening prevention through early detection: a new approach on cancer screening replacing CR. Urology. 2016, 88:125-34.","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2015.09.035","article-title":"Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population","volume":"88","author":"Fascelli M","year":"2016","unstructured":"Fascelli M, Rais-Bahrami S, Sankineni S, et al.. Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population. Urology. 2016, 88:125-34. 10.1016\/j.urology.2015.09.035","journal-title":"Urology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83663","article-title":"The accuracy of biparametric prostate MRI in the pathway of patients with prostate cancer","volume":"17","author":"Ion RT","year":"2025","unstructured":"Ion RT, Serbanoiu A, Salcianu AI, Popa MN, Filipoiu FM, Bratu AM. The accuracy of biparametric prostate MRI in the pathway of patients with prostate cancer. Cureus. 2025, 17:e83663. 10.7759\/cureus.83663","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25641","article-title":"Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD trial)","volume":"46","author":"Jambor I","year":"2017","unstructured":"Jambor I, Bostr\u00f6m PJ, Taimen P, et al.. Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD trial). J Magn Reson Imaging. 2017, 46:1089-95. 10.1002\/jmri.25641","journal-title":"J Magn Reson Imaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.05.024","article-title":"Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer","volume":"38","author":"Stevens E","year":"2020","unstructured":"Stevens E, Truong M, Bullen JA, Ward RD, Purysko AS, Klein EA. Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urol Oncol. 2020, 38:846.e9-846.e16. 10.1016\/j.urolonc.2020.05.024","journal-title":"Urol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders GJ","year":"2020","unstructured":"van Leenders GJ, van der Kwast TH, Grignon DJ, et al.. The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol. 2020, 44:e87-99. 10.1097\/PAS.0000000000001497","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29538","article-title":"Prevalence of incidental prostate cancer: a systematic review of autopsy studies","volume":"137","author":"Bell KJ","year":"2015","unstructured":"Bell KJ, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: a systematic review of autopsy studies. Int J Cancer. 2015, 137:1749-57. 10.1002\/ijc.29538","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09334.x","article-title":"Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology","volume":"106","author":"Droz JP","year":"2010","unstructured":"Droz JP, Balducci L, Bolla M, et al.. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int. 2010, 106:462-9. 10.1111\/j.1464-410X.2010.09334.x","journal-title":"BJU Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.09.014","article-title":"Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes","volume":"185","author":"Brassell SA","year":"2011","unstructured":"Brassell SA, Rice KR, Parker PM, Chen Y, Farrell JS, Cullen J, McLeod DG. Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes. J Urol. 2011, 185:132-7. 10.1016\/j.juro.2010.09.014","journal-title":"J Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots IG","year":"2021","unstructured":"Schoots IG, Padhani AR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int. 2021, 127:175-8. 10.1111\/bju.15277","journal-title":"BJU Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76786-9","article-title":"The use of prostate specific antigen density to predict clinically significant prostate cancer","volume":"10","author":"Yusim I","year":"2020","unstructured":"Yusim I, Krenawi M, Mazor E, Novack V, Mabjeesh NJ. The use of prostate specific antigen density to predict clinically significant prostate cancer. Sci Rep. 2020, 10:20015. 10.1038\/s41598-020-76786-9","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-024-03771-w","article-title":"Precision in prostate cancer detection: integrating prostate-specific antigen density (PSAD) and the Prostate Imaging Reporting and Data System (PI-RADS) to provide additional risk stratification for a more accurate diagnostic decision","volume":"193","author":"Hrub\u00e1 T","year":"2024","unstructured":"Hrub\u00e1 T, Kubas V, Franko M, Bal\u00e1\u017e V, Spurn\u00fd M, Mi\u0161tinov\u00e1 JP. Precision in prostate cancer detection: integrating prostate-specific antigen density (PSAD) and the Prostate Imaging Reporting and Data System (PI-RADS) to provide additional risk stratification for a more accurate diagnostic decision. Ir J Med Sci. 2024, 193:2635-42. 10.1007\/s11845-024-03771-w","journal-title":"Ir J Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000393","article-title":"Active surveillance for low-risk prostate cancer","volume":"27","author":"Klotz L","year":"2017","unstructured":"Klotz L. Active surveillance for low-risk prostate cancer. Curr Opin Urol. 2017, 27:225-30. 10.1097\/MOU.0000000000000393","journal-title":"Curr Opin Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed HU","year":"2017","unstructured":"Ahmed HU, Bosaily AE-S, Brown LC, et al.. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017, 389:815-22. 10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.09.035","article-title":"Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study","volume":"87","author":"Twilt JJ","year":"2025","unstructured":"Twilt JJ, Saha A, Bosma JS, et al.. Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study. Eur Urol. 2025, 87:240-50. 10.1016\/j.eururo.2024.09.035","journal-title":"Eur Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14538","article-title":"Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer","volume":"123","author":"Van Nieuwenhove S","year":"2019","unstructured":"Van Nieuwenhove S, Saussez TP, Thiry S, et al.. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer. BJU Int. 2019, 123:411-20. 10.1111\/bju.14538","journal-title":"BJU Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017162020","article-title":"Detection of clinically significant prostate cancer: short dual-pulse sequence versus standard multiparametric mr imaging-a multireader study","volume":"284","author":"Barth BK","year":"2017","unstructured":"Barth BK, De Visschere PJ, Cornelius A, Nicolau C, Vargas HA, Eberli D, Donati OF. Detection of clinically significant prostate cancer: short dual-pulse sequence versus standard multiparametric mr imaging-a multireader study. Radiology. 2017, 284:725-36. 10.1148\/radiol.2017162020","journal-title":"Radiology"},{"key":"ref28","article-title":"Biparametric versus multiparametric MRI with non-endorectal coil at 3T in the detection and localization of prostate cancer","volume":"37","author":"Scialpi M","year":"2017","unstructured":"Scialpi M, Prosperi E, D\u2019andrea A, et al.. Biparametric versus multiparametric MRI with non-endorectal coil at 3T in the detection and localization of prostate cancer. Anticancer Res. 2017, 37:1263-71.","journal-title":"Anticancer Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.19880","article-title":"Head-to-head comparison between biparametric and multiparametric MRI for the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"211","author":"Woo S","year":"2018","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH, Moon MH. Head-to-head comparison between biparametric and multiparametric MRI for the diagnosis of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2018, 211:W226-41. 10.2214\/AJR.18.19880","journal-title":"AJR Am J Roentgenol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070280","article-title":"Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol","volume":"13","author":"Asif A","year":"2023","unstructured":"Asif A. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open. 2023, 13:e070280. 10.1136\/bmjopen-2022-070280","journal-title":"BMJ Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388886-a-report-on-the-use-of-biparametric-mri-in-prostate-cancer-diagnosis-a-two-year-single-centre-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:08:43Z","timestamp":1757045323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388886-a-report-on-the-use-of-biparametric-mri-in-prostate-cancer-diagnosis-a-two-year-single-centre-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.91630","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}